Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
Biogen's Leqembi launch challenges impact stock growth; Spinraza faces competition. Analyst lowers price target to $316, citing uncertainties.
This Warren Buffett Top 10 Stock Is Falling After Q4 Earnings Report – Here’s Why
Kraft Heinz navigates challenges in Q4 2023 with $6.86 billion sales, down 7.1%. Earnings at $757 million, EPS $0.78 (8.2% decrease). CEO outlines 2024 outlook, projects adjusted earnings of $3.01-$3.07/share.
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What’s Driving Markets Wednesday?
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings.
Charles River Laboratories Stock Surges On Upbeat Annual Outlook, But This Analyst Is Concerned
Charles River Laboratories Q4 2023 revenue: $1.01 billion, down 7.9% YoY, beating consensus. Analysts note mixed Q4 performance, keeping Outperform rating.
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.
Nearly Half Of S&P 500 Stocks Trade Below 50-Day Moving Average: Which One Is The Cheapest?
Nearly half of S&P 500 stocks are below 50-day moving average, indicating poor market breadth. Only top 5 companies shielded from bearish pressures.
Cardiology’s Quantum Leap: FDA’s Advisory Panel Gives Thumbs Up To Abbott’s Minimally Invasive Heart Valve Repair Device
FDA panel confirms support (13-1) for Abbott Laboratories' TriClip TEER system in treating tricuspid regurgitation. Approval decision expected from FDA in 2024.
Budget-Friendly Tesla Slayer? Sony & Honda Reportedly Join Hands For Affordable EVs
Sony Honda Mobility, a joint venture between Honda and Sony, reportedly plans to launch three electric vehicle models by late 2020s to compete with Tesla.
Bullish Q4 Earnings, Modest Guidance: Can Building Materials Supplier Owens Corning Find the Right Roof?
Owens Corning reported Q4 net sales of $2.30B, beating consensus. Adjusted EPS and EBIT increased, while cash flow was $1.7B. Q1 sales is expected to be slightly lower compared to prior year.
Building Blocks of Success: Martin Marietta Materials Beats On Earnings, Eyes Recovery Despite Housing Wobble
Martin Marietta Materials reported Q4 FY23 results, with revenue of $1.608B and EPS of $4.63. The company expects strong demand for aggregates in FY24.